ADMA Biologics is a biopharmaceutical company relentlessly committed to creating superior products for immunodeficient patients at risk for infection. It is our devotion to this underserved population that fuels us and our hands-on approach to production and development that sets us apart. If you are looking for a dynamic, innovative, growing company in the biopharmaceutical industry that is committed to excellence and integrity, then consider ADMA Biologics. We currently have an exciting opportunity available for a Technician I, Fractionation (Night Shift) in Boca Raton, Florida!
This position is under the direct supervision of the Group Leader with support and assistance from the Advanced Tech positions. This entry-level position helps with the manufacturing of plasma products by Cleaning and sanitizing of equipment and processing areas, preparation of buffer solutions, and other tasks involving plasma receipt, pooling and protein separation.
Cleans and Sanitizes Equipment before and after use.
Cleans and Sanitizes Manufacturing Areas daily.
Operates COP washer.
Receives and de-boxes plasma units.
Operates plasma bottle cutter.
Operates pooling tank lift.
Set up and harvest centrifuges.
Monitors centrifuge flow and temperatures.
Prepares buffer solutions.
Removes trash (empty plasma bottles, etc) from the TCP and Fractionation areas.
Maintains stock of gowning supplies.
Make connections on flow panels for product transfers.
Follow manufacturing SOP’s and Batch Records.
Additional tasks associated with advancement to the Tech II position.
Ability to follow the cGMP’s and procedures with great attention to detail
Education Requirements: High School Diploma or GED. Associate degree or equivalent experience preferred.
Preferred Experience: GMP experience preferred.
As a part of our Quality Systems and cGMP initiatives, employees are responsible for ensuring compliance with all ADMA Quality policies, standards and SOPs in their area of work and responsibility. This includes ensuring all Quality Assurance (QA) records and reports, Human Resources (HR) policies, and Environmental Health and Safety (EH&S) procedures and practices are completed in a timely manner. Any delay or failure to comply with policies, standards and procedures is required to be communicated/escalated to the appropriate responsible parties, such as QA, HR, or EH&S depending on the issue.
In addition to competitive compensation, we offer a comprehensive benefits package including:
ADMA Biologics is an Equal Opportunity Employer.

ADMA Biologics is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. ADMA currently manufactures and markets three United States Food and Drug Administration (FDA) approved plasma-derived biologics for the treatment of immune deficiencies and the prevention of certain infectious diseases: BIVIGAM® (immune globulin intravenous, human) for the treatment of primary humoral immunodeficiency (PI); ASCENIV™ (immune globulin intravenous, human – slra 10% liquid) for the treatment of PI; and NABI-HB® (hepatitis B immune globulin, human) to provide enhanced immunity against the hepatitis B virus. ADMA manufactures its immune globulin products at its FDA-licensed plasma fractionation and purification facility located in Boca Raton, Florida. Through its ADMA BioCenters subsidiary, ADMA also operates as an FDA-approved source plasma collector in the U.S., which provides a portion of its blood plasma for the manufacture of its products. ADMA’s mission is to manufacture, market and develop specialty plasma-derived, human immune globulins targeted to niche patient populations for the treatment and prevention of certain infectious diseases and management of immune compromised patient populations who suffer from an underlying immune deficiency, or who may be immune compromised for other medical reasons. ADMA has received U.S. Patents: 9,107,906, 9,714,283, 9,815,886, 9,969,793 and 10,259,865 related to certain aspects of its products and product candidates. For more information, please visit www.admabiologics.com.